Diltiazem HCl Chew Treat
Diltiazem HCl is a compounded formulation containing Diltiazem HCl, prepared by Mixlab for veterinary use. Available by prescription.
Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider diltiazem for patients presented with heart disease, particularly hypertrophic cardiomyopathy (HCM) in feline patients. It is also frequently discussed in the context of supraventricular tachyarrhythmias, where managing a rapid or irregular heart rate is a primary clinical objective. The decision to select diltiazem is typically based on diagnostic findings from an echocardiogram or electrocardiogram (ECG) to confirm the structural and electrical status of the heart.
At a pharmacological level, diltiazem acts by inhibiting the influx of calcium ions through L-type voltage-gated channels in cardiac and vascular smooth muscle. This mechanism manages the depolarization process, which relaxes coronary and systemic blood vessels and slows electrical conduction through the atrioventricular (AV) node. By managing these physiological pathways, the medication provides a method for reducing the heart’s workload, managing blood pressure and supporting the heart’s ability to relax and fill with blood (diastolic function). Diltiazem is characterized by its relative selectivity for the myocardium and conduction system. Your veterinarian will determine the clinical appropriateness of diltiazem based on your pet’s specific cardiac profile, diagnostic results and health status.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of diltiazem include localized digestive changes such as vomiting or a temporary decrease in appetite. Some animals may exhibit behavioral shifts including lethargy, weakness or a noticeable decrease in energy. Because diltiazem influence heart rhythm and vascular tone, your veterinarian will monitor for observational signs of a slow heart rate (bradycardia) or low blood pressure (hypotension). Owners should monitor their pet for any unusual fainting episodes, significant coordination changes or persistent changes in activity levels and contact their veterinarian promptly with any concerns.
This medication is typically used with extra caution or avoided in patients with known severe renal or hepatic impairment, as well as those presented with specific types of heart block or congestive heart failure. It is also carefully evaluated in pets with pre-existing low blood pressure. Significant interactions can occur if diltiazem is administered concurrently with other heart medications, specific diuretics, beta-blockers or certain immunosuppressants like cyclosporine. Your veterinarian is the right person to provide guidance on the necessary duration of use and the most appropriate monitoring schedule—which may include periodic blood pressure checks and repeat ECGs—to ensure the management approach remains suitable for your pet's cardiac health.
Yes. Diltiazem is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all legal authorizations before any medication is prepared or shipped to your home.
Yes. While diltiazem is available in various commercial tablet and capsule formats for humans, Mixlab specializes in compounding the active ingredient into customized strengths and flavored dosage forms—such as flavored oral liquids or smaller capsules—to suit the specific needs of dogs and cats. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians often discuss diltiazem for cats with hypertrophic cardiomyopathy because it is used in the context of supporting the heart's ability to relax and fill with blood. Its mechanism provides a method for managing the heart's workload and supporting overall cardiovascular function in patients with thickened heart muscles.
The most important observational signs to monitor include changes in energy levels, appetite or activity. You should also watch for any unusual weakness, fainting or a very slow heart rate and report these to your veterinarian immediately for a clinical review of the management plan.
Veterinarians often provide specific instructions regarding administration, as the presence of food can influence the rate of absorption for certain diltiazem formulations. Your veterinarian will provide guidance on the most consistent administration schedule to ensure the medication provides a stable physiological influence.
